A Selective Galactose–Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model
-
- Vishal K. Rajput
- Indian Institute of Science Education and Research-Kolkata (IISER) Kolkata, Mohanpur Campus, P.O. BCKV Campus Main Office, Mohanpur, Nadia 741246, India
-
- Alison MacKinnon
- MRC Centre for Inflammation Research, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, U.K.
-
- Santanu Mandal
- Centre for Analysis and Synthesis, Department of Chemistry, Lund University, POB 124, SE-221 00 Lund, Sweden
-
- Patrick Collins
- Institute for Glycomics, Griffith University, Gold Coast Campus, Parklands Southport, Queensland 4222, Australia
-
- Helen Blanchard
- Institute for Glycomics, Griffith University, Gold Coast Campus, Parklands Southport, Queensland 4222, Australia
-
- Hakon Leffler
- Department of Laboratory Medicine, Section MIG, Lund University, BMC-C1228b, Klinikgatan 28, SE-221 84 Lund, Sweden
-
- Tariq Sethi
- Department of Respiratory Medicine and Allergy, Kings College, Denmark Hill Campus, Bessemer Road, London SE5 9RS, U.K.
-
- Hans Schambye
- Galecto Biotech ApS, COBIS, Ole Maaloes vej 3, Copenhagen N, DK-2200, Denmark
-
- Balaram Mukhopadhyay
- Indian Institute of Science Education and Research-Kolkata (IISER) Kolkata, Mohanpur Campus, P.O. BCKV Campus Main Office, Mohanpur, Nadia 741246, India
-
- Ulf J. Nilsson
- Centre for Analysis and Synthesis, Department of Chemistry, Lund University, POB 124, SE-221 00 Lund, Sweden
収録刊行物
-
- Journal of Medicinal Chemistry
-
Journal of Medicinal Chemistry 59 (17), 8141-8147, 2016-08-23
American Chemical Society (ACS)